H.C. Wainwright analyst Edward White downgraded Vyant Bio to Neutral from Buy without a price target after the company announced a workforce reduction to preserve cash. The analyst cites the change in management along with the uncertainty surrounding exploring strategic alternatives for the downgrade.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on VYNT: